Skip to content

Kewaunee Scientific Corporation KEQU Share Repurchase Authorization Limit

Share Repurchase Authorization Limit at other companies

Lifetime Brands logo
Lifetime BrandsLCUT
$11.1M0.0%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$71.4M-7.5%
Gross profit$21.2M-11.6%
Operating income$5.2M-38.6%
Net income$3.4M-30.1%
EPS (diluted)$1.13-30.7%

Balance sheet

See full
Cash & equivalents$10.0M-42.0%
Total debt$25.3M+6.6%
Total equity$74.7M+15.9%
Total assets$178.3M-8.4%

Cash flow

See full
Operating cash flow$5.5M-42.0%
CapEx$928.0K+79.8%
Free cash flow$4.5M-49.0%

Valuation

See full
Market cap$101.96M-32.7%
Enterprise value$117.3M-26.0%
P/E10.6×-2.7×
P/S0.4×-0.3×

Profitability

See full
Gross margin28.5%-0.1pp
Operating margin5.9%-1.5pp
Net margin3.4%-1.3pp
FCF margin5.2%

Returns & leverage

See full
Return on equity13.8%-5.3pp
Debt / equity0.3×0.0×
Current ratio2.2×0.0×

Where this comes from

Reported directly by Kewaunee Scientific Corporation in its filing.

Tagged under the XBRL concept us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased.

The official record: Kewaunee Scientific Corporation’s 10-Q, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kewaunee Scientific Corporation's share repurchase authorization limit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kewaunee Scientific Corporation's share repurchase authorization limit?
Kewaunee Scientific Corporation (KEQU) reported share repurchase authorization limit of 100.6K in Q4 2025.
How has Kewaunee Scientific Corporation's share repurchase authorization limit changed year-over-year?
Kewaunee Scientific Corporation's share repurchase authorization limit increased by 197.6% year-over-year, from 33.8K to 100.6K.
What does share repurchase authorization limit mean?
This represents the total dollar value or share count that the board of directors has authorized the company to spend on repurchasing its own common stock from the open market. It serves as a signal of management's confidence in the company's valuation and its commitment to returning capital to shareholders. This limit is an authorization, not an obligation to spend.